Curated News
By: NewsRamp Editorial Staff
October 28, 2025
HeartBeam Partners with HeartNexus for 24/7 Remote Cardiac Monitoring
TLDR
- HeartBeam's partnership with HeartNexus provides competitive advantage through 24/7 cardiology services that capture patients outside traditional healthcare settings.
- HeartBeam's patented 3D technology captures 30-second cable-free ECG recordings that transmit data to HeartNexus cardiologists for immediate interpretation and analysis.
- This partnership makes cardiac monitoring accessible beyond medical facilities, improving heart health management and potentially saving lives through timely interventions.
- HeartBeam's FDA-cleared 3D ECG technology can record heart signals from three directions and synthesize them into a 12-lead ECG anywhere.
Impact - Why it Matters
This partnership represents a significant advancement in accessible cardiac care, addressing the critical gap in monitoring heart conditions outside clinical settings. For millions of people at risk of cardiac events, this technology means faster detection and intervention when symptoms occur, potentially saving lives by reducing the time between symptom onset and medical response. The 24/7 availability of cardiologist interpretation through HeartNexus provides peace of mind for patients with known heart conditions and those experiencing unexplained symptoms. As cardiovascular disease remains the leading cause of death globally, innovations like HeartBeam's portable 3D ECG technology combined with immediate professional analysis could dramatically improve outcomes by enabling early detection and timely treatment of cardiac events that might otherwise go unmonitored or undiagnosed until it's too late.
Summary
HeartBeam (NASDAQ: BEAT), a pioneering medical technology company, has announced a strategic partnership with HeartNexus Inc., a specialized network of board-certified cardiologists, to revolutionize cardiac care delivery. This collaboration enables HeartBeam to offer comprehensive 24/7 cardiology reader services for patients experiencing cardiac symptoms outside traditional healthcare settings. Utilizing HeartBeam's groundbreaking patented 3D technology, patients can now capture 30-second, cable-free ECG recordings whenever symptoms occur and transmit the data directly to HeartNexus cardiologists for immediate professional interpretation. Robert Eno, CEO of HeartBeam, emphasized that "working with HeartNexus accelerates our mission to make medical-grade cardiac monitoring accessible beyond the walls of a medical facility." This partnership significantly expands HeartBeam's ecosystem by integrating real-time cardiology feedback and paving the way for future AI wellness and wearable technology integration.
HeartBeam's innovative platform represents a major advancement in cardiac health management, creating the first-ever cable-free device capable of collecting ECG signals in three non-coplanar directions and synthesizing them into a comprehensive 12-lead ECG. This technology, which received FDA clearance for arrhythmia assessment in December 2024, is designed for portable use wherever patients are located, delivering actionable heart intelligence directly to physicians. The company's approach allows healthcare providers to identify cardiac health trends and acute conditions while directing patients to appropriate care—all without requiring physical presence in medical facilities. With over 20 issued patents supporting their technology enablement and their 12-Lead ECG synthesis software currently under FDA review, HeartBeam is positioned to redefine the future of cardiac health management through their innovative solutions available through the InvestorBrandNetwork.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, HeartBeam Partners with HeartNexus for 24/7 Remote Cardiac Monitoring
